MindwaysCT has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its asynchronous QCT calibration technology for CT-based bone mineral density measurement.(PRWeb September 24, 2014)Read the full story at http://www.prweb.com/releases/2014/09/prweb12193211.htm
